List view / Grid view

Active Pharmaceutical Ingredient (API)

 

article

What to consider when formulating bacteriophages

22 November 2021 | By ,

In this article, Dr Michael Koeris, Associate Professor, Bioprocessing at Keck Graduate Institute, and Carolina Moraes de Souza, Keck MEng graduate, now Process Development Senior Associate at Amgen, discuss the key formulation considerations for bacteriophages, a potential solution to antimicrobial resistance, and why process development should be an early consideration.